This announcement is a separate document:
国浩律师（杭州）事务所关于江苏诺泰澳赛诺生物制药股份有限公司2023年限制性股票激励计划第一个归属期归属条件成就、授予价格调整及部分限制性股票作废相关事项的法律意见书
Guohao Law Firm (Hangzhou) legal opinion on the achievement of the first vesting condition, adjustment of grant price, and cancellation of certain restricted stocks related to Jiangsu Nuo Tai Ao Sai Nuo Biopharmaceutical Co., Ltd.'s restricted stock incentive plan for 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.